Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Piroxicam 0.5% gel
1003020R0AAAAAA
|
Piroxicam (Topical) | Piroxicam | Musculoskeletal and Joint Diseases | 68,653 |
|
Feldene 0.5% gel
1003020R0BBAAAA
|
Feldene (Rubefacient) | Piroxicam | Musculoskeletal and Joint Diseases | 1,768 |
|
Piroxicam 20mg capsules
1001010R0AAABAB
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 1,349 |
|
Piroxicam 10mg capsules
1001010R0AAAAAA
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 944 |
|
Piroxicam 20mg orodispersible tablets sugar free
1001010R0AAAGAG
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 327 |
|
Feldene Melt 20mg tablets
1001010R0BBAGAG
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 268 |
|
Feldene 20 capsules
1001010R0BBABAB
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 161 |
|
Feldene 10mg capsules
1001010R0BBAAAA
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 118 |
|
Brexidol 20mg tablets
1001010R0BHAAAK
|
Brexidol | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Feldene 10mg dispersible tablets
1001010R0BBACAD
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Feldene 20mg dispersible tablets
1001010R0BBADAE
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Feldene 20mg suppositories
1001010R0BBAEAC
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Feldene IM 20mg/1ml solution for injection ampoules
1001010R0BBAFAH
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Feldene P 0.5% gel
1003020R0BBACAA
|
Feldene (Rubefacient) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 10mg dispersible tablets
1001010R0AAADAD
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg dispersible tablets
1001010R0AAAEAE
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg suppositories
1001010R0AAACAC
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg/1ml solution for injection ampoules
1001010R0AAAHAH
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam betadex 20mg tablets
1001010R0AAAKAK
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Pirozip 10 capsules
1001010R0BDAAAA
|
Pirozip | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Pirozip 20 capsules
1001010R0BDABAB
|
Pirozip | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.